Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WHO On Dire Need For Essential Medicines In Ukraine

Latest Flight Leaves UK With Drug Supplies

Executive Summary

As Russia continues its invasion of Ukraine by bombarding cities across the country, the World Health Organization and the UK government have issued updates on the medicines and other medical supplies they are donating to Ukraine, and the urgency of the situation on the ground.

You may also be interested in...

TB Alliance CEO On Derailed Treatment In Ukraine, Pediatric Pretomanid Plans

TB Alliance CEO Mel Spigelman discusses the huge disruptions in TB treatment in war-ravaged Ukraine, and need for funding, political will and resources along the lines of that galvanized for COVID-19, or "even a fraction" of that, to control the deadly infectious disease. He also touched on the accelerated availability of the BPaL regimen and a partnered program for an anti-TB natural product.

EU Boosts COVID-19 Vaccine Supplies With Moderna & HIPRA Deals

New supply arrangements with the two firms are expected to offer greater protection to people in Europe as the autumn/winter season approaches. The EU’s health crisis preparedness body HERA has also identified its “top three health threats.”

Aspen Setback Illustrates Need For Africa To Build Up Vaccines Market

A coordinated effort will be needed if Africa is to increase its manufacturing capacity and ensure a market for domestically produced vaccines.

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts